MS Medisol OÜ is a OÜ based in Räni alevik, registry code 11903768, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €0 with employees.
Turnover
0 €
State taxes
3 482 €
↑ 248.2%vs Q2 2026
Labour taxes
1 000 €
↑ 0.0%vs Q2 2026
Employees
—
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry Scientific research and development · EMTAK 72
Revenue · 202559 153 €
above 88% of companies
industry median 0 € · companies in the industry: 1 073
Net profit margin · 202548.2 %
above 70% of companies
industry median 13.5 % · companies in the industry: 597
Taxes and turnover
Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
State taxes, € Q3 2026: 3 482 € · +248.2% vs Q2 2026
Figures by quarter
Quarter
Turnover, €
State taxes, €
Labour taxes, €
Employees
Q3 2026
—
3 482
1 000
—
Q2 2026
—
1 000
1 000
—
Q1 2026
—
1 154
1 154
—
Q4 2025
5 554
1 462
1 462
—
Q3 2025
15 723
1 463
1 462
—
Q2 2025
23 100
2 737
2 737
—
Q1 2025
21 457
5 182
5 182
—
Q4 2024
17 762
4 970
4 969
—
Q3 2024
15 455
4 969
4 969
—
Q2 2024
11 302
4 977
4 969
—
Q1 2024
13 029
4 980
4 969
—
Q4 2023
19 165
13 987
7 237
—
Q3 2023
16 005
4 969
4 969
—
Q2 2023
19 507
4 306
4 306
—
Q1 2023
15 430
3 976
3 975
—
Q4 2022
17 977
10 915
5 377
—
Q3 2022
20 004
1 068
1 040
—
Q2 2022
17 608
1 040
1 040
—
Q1 2022
14 904
1 003
1 003
—
Financials by year
2016 – 2025
Revenue, € 2025: 59 153 € · +1.0% vs 2024 · industry median 0 € · above 88% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit, € 2025: 28 530 € · +1 657.9% vs 2024 · industry median 0 € · above 90% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit margin, % 2025: 48.2 % · +45.5 pp vs the year before · industry median 13.5 % · above 70% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Assets, € 2025: 48 742 € · +127.4% vs 2024Equity, € 2025: 47 836 € · +147.8% vs 2024Employees2025: 1 · +0.0% vs 2024 · industry median 1 · above 5% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Financials by year
Year
Revenue, €
Net profit, €
Labour costs, €
Assets, €
Equity, €
Employees
2025
59 153
28 530
23 394
48 742
47 836
1
2024
58 561
1 623
49 875
21 436
19 306
1
2023
69 893
8 269
46 550
19 857
17 684
1
2022
70 732
41 046
17 804
49 375
47 715
1
2021
65 611
31 305
22 171
41 325
40 681
1
2020
70 415
37 001
21 613
46 041
44 376
1
2019
59 853
22 718
19 950
36 865
35 593
1
2018
—
—
—
—
—
1
2017
—
—
—
—
—
1
2016
—
—
—
—
—
0
2015
—
—
—
—
—
0
2014
—
—
—
—
—
1
2013
—
—
—
—
—
1
2012
—
—
—
—
—
1
2011
—
—
—
—
—
1
2010
—
—
—
—
—
1
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
48.2 %
Net profit / revenue
Return on equity (ROE)
59.6 %
Net profit / equity
Return on assets (ROA)
58.5 %
Net profit / assets
Equity ratio
98.1 %
Equity / assets
Debt ratio
1.9 %
Liabilities / assets
Current ratio
53.80
Current assets / current liabilities
Revenue per employee
59 153 €
Revenue / average full-time employees
Labour cost per employee per month
1 950 €
Labour costs / employees / 12 months (incl. employer taxes)
